Atlas Trials

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Clinical trial NCT06482554 · RECRUITING

Trial details

NCT number
NCT06482554
Sponsor
Louisiana State University Health Sciences Center Shreveport
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ApathySchizophreniaSchizophrenia; Psychosis
Start date
2024-06-01
Primary completion
2026-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.